Let's check out two exciting biotech stocks that may climb 58% and 200%, according to Wall Street. Image source: Getty Images ...

President Donald Trump urged Iran to reach a deal through diplomacy and alluded to potential military action if talks fail as he made remarks at the first meeting of his Board of Peace. Follow for ...

“Regulated manufacturers increasingly rely on Kneat because of its trusted system of record for validation, built to support the highest standards of data integrity and compliance. We’re excited to ...

NBA player rankings don't sit still. Back in October, we stacked the top players in the league ahead of the season. What followed was an inevitable whirlwind of trades, injuries, slumps and breakouts, ...

Citi's Global Industrial Tech & Mobility Conference 2026 February 19, 2026 11:20 AM ESTCompany ParticipantsRobert Cardillo - ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results.

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for ...

Boehringer Ingelheim recently announced that 2 of its products, NexGard and NexGard COMBO, received Emergency Use Authorization (EUA) for treating New World screwworm (NWSW) myiasis in both feline and ...

The USDA announced it has granted Emergency Use Authorization (EUA) to afoxolaner chewable tablets (NexGard;Boehringer Ingelheim) for treating New World screwworm (NWS) myiasis in canines, and ...

This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

Many employees for the US’ sole agency dedicated to worker health and safety are returning to work, but the time away could introduce obstacles in getting back to their research.